Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting*Kim S Thomas, Norito Katoh, Erin E. Grinich et al.|British Journal of Dermatology|2021Cited by 88
Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) InitiativeErin E. Grinich, Eric L. Simpson, Jochen Schmitt et al.|British Journal of Dermatology|2018Cited by 44
Measuring Atopic Eczema Control and Itch Intensity in Clinical PracticeYael A. Leshem, Joanne R Chalmers, Christian Apfelbacher et al.|JAMA Dermatology|2022Cited by 36
Measurement properties of patient‐reported outcome measures for eczema control: a systematic reviewBeth Stuart, Kim S Thomas, Laura Howells et al.|Journal of the European Academy of Dermatology and Venereology|2021Cited by 13
Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meetingKim S Thomas, Norito Katoh, Christian Apfelbacher et al.|British Journal of Dermatology|2020Cited by 12